Sign In
Buy CERT
$5.60
-0.0200 (-0.356%)
At Close: Jun 03, 2026
Certara to Participate in the Jefferies Global Healthcare Conference
04:15pm, Friday, 02'nd Jun 2023
PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Heal
Certara, Inc. (CERT) Q1 2023 Earnings Call Transcript
07:49pm, Monday, 08'th May 2023
Certara, Inc. (NASDAQ:CERT ) Q1 2023 Results Conference Call May 8, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO John Gallagher - CFO Conference Call Participants Dav
5 Must-Buy High-Flying Mid-Cap Stocks Ahead of Q1 Earnings
08:23am, Friday, 28'th Apr 2023
We have narrowed our search to five stocks that are set to report first-quarter 2023 earnings results. These are: SHAK, WING, AMK, PRI and CERT.
PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2023
MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study
01:42pm, Thursday, 06'th Apr 2023
As MorphoSys (MOR) completes enrolment before schedule in a late-stage study evaluating therapy in myelofibrosis patients, the top-line data from this study is now expected early.
GSK's Jemperli Effective Against First-Line Endometrial Cancer
04:45pm, Tuesday, 28'th Mar 2023
A late-stage study data shows that GSK's Jemperli reduced disease progression risk or death by 72% for treating adult patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer.
Are These 3 Small Momentum Stocks Setting Up Big Gains?
07:11am, Wednesday, 22'nd Mar 2023
MINISO Group Holding Limited (NYSE: MNSO), PDF Solutions Inc. (NASDAQ: PDFS), and Certara Inc. (NASDAQ: CERT) are relatively unknown stocks currently showing strong price momentum.
Best Momentum Stocks to Buy for March 15th
11:28am, Wednesday, 15'th Mar 2023
CERT, BWMX and NUE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 15, 2023.
New Strong Buy Stocks for March 15th
08:27am, Wednesday, 15'th Mar 2023
TRIN, CERT, WPP, NUE and BHR have been added to the Zacks Rank #1 (Strong Buy) List on March 15, 2023.
Can Certara, Inc. (CERT) Run Higher on Rising Earnings Estimates?
01:43pm, Thursday, 09'th Mar 2023
Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Certara, Inc. (CERT) Tops Q4 Earnings and Revenue Estimates
07:34pm, Wednesday, 01'st Mar 2023
Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Certara to Participate in the Barclays Global Healthcare Conference
04:30pm, Monday, 27'th Feb 2023
PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Barclays Global Healt
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
04:30pm, Wednesday, 01'st Feb 2023
PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and ful
CERT vs. PBYI: Which Stock Should Value Investors Buy Now?
12:48pm, Monday, 09'th Jan 2023
CERT vs. PBYI: Which Stock Is the Better Value Option?
Why Certara Is A Buy For 2023
07:57am, Tuesday, 06'th Dec 2022
Unlike Schrodinger, Certara posted a profit in the last quarter. Business momentum is accelerating as backlog grows.
